p53 is a tumor suppressor that responds to various stress signals by initiating cell-cycle arrest, senescence and apoptosis. Mutations of the p53 gene are found in over 50% of human tumors, highlighting the importance of p53 in tumor suppression. Numerous studies have reported on the interactions between p53, IGF-1-AKT and mTOR pathways as potentially explaining some of the tumor suppressive activities of p53. To further understand the basis of these interactions, we analyzed the involvement of DJ-1, an oncogene known to drive AKT-mediated cell survival, in the p53-AKT axis. In this study, we show that DJ-1 and p53 are tightly 'linked': p53 prevents the accumulation of DJ-1 protein, whereas loss of p53 leads to stabilization and enhancement of DJ-1 expression. Interestingly, this increase in DJ-1 level is only observed when p53 loss is accompanied by transformation of cells. Moreover, DJ-1 seems to be required for the enhanced activation of AKT observed in p53-deficient cells. Such observation confers a new property to DJ-1 associated to transforming-process to its oncogenic ability to drive AKT activation. We also show that DJ-1 is necessary for p53 activation following oxidative stress, suggesting the existence of a finely regulated loop between these two proteins in transformed cells. Finally, we demonstrate that in the absence of p53, DJ-1 is stabilized by ROS accumulation, and surprisingly seems to be required for this high intracellular ROS production. These data offer new insights into the regulation of DJ-1 and suggest that DJ-1 is a target of p53. Importantly, our study highlights that during transformation, DJ-1 is having a key role in the p53-regulated AKT pathway and p53-driven oxidative-stress response.
Introduction
The p53 pathway senses various intrinsic and extrinsic stress signals, including DNA damage, metabolic changes, hypoxia and oncogenic activation. In response to these stress signals, the tumor suppressor p53 regulates transcription of genes mediating cell-cycle arrest, DNA repair, differentiation, metabolic adaptation and/ or apoptosis (Vousden and Prives, 2009) . Balance between cell growth and cell-cycle arrest is regulated through interactions between p53 and IGF-1/AKT/ mTOR pathway. There is an abundance of literature supporting the notion that, upon stress, p53 negatively regulates the IGF-1/AKT pathway by inducing the expression of p53-target genes such as IGF-BP3 or PTEN, which shut down IGF-1/AKT pathway or decrease activation of AKT, respectively (Feng, 2010) . With respect to p53-dependent activation of PTEN, increased PTEN levels diminish the function of PIP 3 in the activation of PDK-1 and mTORC2, which in turns inhibits the activity of AKT, leading to decreased cell proliferation. On the other hand, activation of AKT in the presence of growth factors leads to the AKTdependent activation of MDM2, which in turns degrades and inactivates p53, creating a feedback loop in the p53-AKT pathway (Gottlieb et al., 2002) .
DJ-1 (CAP1/RS/PARK7) is a protein described as a protector against oxidative stress in neurons, and is largely documented for its association with Parkinson's disease (Kahle et al., 2009; Aleyasin et al., 2010; Giaime et al., 2010; Guzman et al., 2010; Hao et al., 2010) . DJ-1 is also referred to as an oncogene and found to be overexpressed in many types of tumors (Hinkle et al., 2011) . Our group demonstrated that DJ-1 confers tumor-cell resistance to hypoxic stress and modulates the activity of mTOR and AMPK (Vasseur et al., 2009) . Previously, its oncogenic potential has also been explained by its ability to activate AKT and hence, inhibiting PTEN signaling (Kim et al., 2005) . As p53 cooperates with PTEN to inhibit AKT, DJ-1 would appear to be a negative regulator of this signaling. Therefore, balance between DJ-1 and p53-dependent pathways must be finely regulated during cell growth and likely impacts on tumor-cell fate. Determining whether and how these seemingly opposing tumorassociated genes influence each other may provide insights into mechanisms of cancer initiation and/or progression. Numerous studies have demonstrated an existing link between p53 and DJ-1, some of them pointing to an antiapoptotic function of DJ-1 through repression of p53 transcriptional activity (Fan et al., 2008) , and others suggesting that p53 might inhibit such function through the induction of DJ-1 phosphorylation (Rahman-Roblick et al., 2008) . In patients with myelodysplastic syndromes, increased DJ-1/p53 ratio in marrow cells was associated with an increase of overall mortality (Marcondes et al., 2010) . Here, we report a strong interconnection between p53, DJ-1 and AKT. We show in vitro and in vivo that p53 loss and transformation are both needed for DJ-1 upregulation. We also demonstrate that the increased DJ-1 protein level is responsible for AKT activation and ROS production in transformed p53-mutated cells. Overall, this study adds new insights into the current understanding of p53's capabilities in repressing pathways leading to tumorigenesis.
Results and discussion
To investigate the relationship between DJ-1 and p53, we compared DJ-1 protein levels in transformed mouse embryonic fibroblasts (MEFs) derived from p53
À/À (knockout) mice. We observed a significant enhancement in DJ-1 level in p53 À/À MEFs (six folds) as compared with p53 þ / þ MEFs, suggesting that p53 exerts an inhibitory effect on DJ-1 protein expression ( Figure 1a ). We found a similar increase of DJ-1 in MEFs harboring a transcriptional mutant of p53, which is impaired in transactivation of p53 target genes (p53 QS MEFs) (Figure 1a ) (Nister et al., 2005) . Therefore, p53-mediated inhibition of DJ-1 is likely exerted by a transcriptional target of p53. However, despite a dramatic upregulation of DJ-1 protein following p53 deletion, DJ-1 mRNA expression showed no increase and promoter analysis using TRANSFAC, and the p53FamTag databases did not reveal any consensus site for p53 (data not shown). We next induced endogenous p53 expression in MEFs using doxorubicin treatment, a strong and rapid inducer of p53. p53 upregulation was accompanied by a marked reduction in DJ-1 protein level, attesting to an inverse relationship between p53 and DJ-1 levels ( Figure 1b ). Our findings indicate that p53 could promote DJ-1 degradation after DNA damage. Analysis of p53-dependent mechanisms leading to DJ-1 degradation upon various stress are currently under investigation. Taken together, these results demonstrate that endogenous p53 decreases DJ-1 protein level by a post-transcriptional route and that DJ-1 expression is determined by p53 status. À/À and DNp73 À/À primary or immortalized MEFs were derived from gene-targeted C57BL6/J background mice and their littermates as previously described (Vasseur et al., 2002; Wilhelm et al., 2010) . Transformed MEFs were obtained by transduction with the E1A and RasV12 oncogenes using retroviral infection (pLPC-E1A-IRES-RasV12) and selected by growth in puromycin. p53
QS transformed MEFs, containing a mutant form of p53 (p53 w25QL26S ) harboring an inactive transactivation domain, were kindly provided by G Wahl. Whole-cell lysates were prepared from transformed p53 þ / þ , p53 À/À and p53 QS treated cells 24 h after plating and treatment by doxorubicin (0.25 mM) (b) or not (a), or from DNp73 þ / þ and knockout immortalized MEFs (c) treated with doxorubicin (0.25 mM) at the indicated time. (d) DP16-1 cell line expressing the murine allele temperature-sensitive (ts) p53 Val-135 (obtained from S Benchimol) was cultured as described (Johnson et al., 1993) , and incubated at 37 1C or 32 1C 24 h after plating. Total-cell lysates were prepared at the indicated times. Levels of DJ-1 and p53 were determined in lysates by western blotting using the following antibodies: rabbit polyclonal anti-p53 (FL-393, Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit polyclonal anti-DJ-1 (Kim et al., 2005) ; mouse monoclonal antib-tubulin (Sigma-Aldrich, St Quentin Fallavier, France). The appropriate secondary antibodies were used and visualized using either the Odyssey Infrared Imaging System (LI-COR, Biosciences, NE, USA; secondary Antibodies Alexa Fluor Dyes, Molecular Probes, Burlington, ON, Canada) or enhanced chemiluminescence (ECL, Amersham, Orsay, France; anti-mouse HRP; anti-rabbit HRP, Santa Cruz Biotechnology). Samples were probed for b-tubulin (b-tub.) as a loading control. Levels of DJ-1 and p53 are normalized to b-tubulin and expressed as fold change relative to base expression observed in untreated p53 
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As it is conceivable that p53 inhibition of DJ-1 is cell-context dependent, we examined p53 regulation of DJ-1 in various cell types. We evaluated DJ-1 protein level in immortalized DNp73-deficient MEFs. Trp73 is a member of Trp53 family gene, known to produce tumor-suppressive TAp73, or oncogenic DNp73 isoforms (Tomasini et al., 2008; Wilhelm et al., 2010) . DNp73 deficiency sensitizes cells to DNA damage, increases the levels of p53 and its target genes and consequently, enhances p53-mediated apoptosis (Wilhelm et al., 2010) . In line with above results, DNp73 À/À immortalized MEFs exhibited a reduction in DJ-1 protein levels as compared with DNp73 þ / þ MEFs. Exposure to doxorubicin led to a further two to four fold reduction in DJ-1 level, as compared with parental DNp73 þ / þ -treated cells (Figure 1c ). Interestingly, despite p53 induction following doxorubicin treatment, wild-type cells harbor comparable levels of DJ-1. Compared with primary or transformed MEFs, immortalized wild-type MEFs have higher sensitivity threshold for doxorubicin and are more resistant to treatment at short-time exposures (data not shown). Hence, it is possible that in such context, p53 induction is not efficient in inhibiting DJ-1 expression. To further confirm our data, the impact of p53 expression on the regulation of DJ-1 protein levels was investigated in the p53-negative Friend erythroleukemia cell line DP16-1 that is stably expressing a temperature-sensitive mutant form of p53 (Johnson et al., 1993) . The p53 protein encoded by the ts p53 allele behaves as a mutant polypeptide at 37 1C and is mainly cytoplasmic. At 32 1C, p53 protein undergoes a conformational change, localizes to the nucleus and behaves as a wild-type polypeptide. When these cells were shifted from 37 1C to 32 1C, DJ-1 levels were significantly reduced at 24 h (Figure 1d ). The slight increase observed in DJ-1 levels after 8 h at 32 1C is likely due to heat shock. Antibody used to detect p53 mutants was not able to recognize the ts protein after conformational change at 32 1C. Therefore, we decided to correlate reduction of DJ-1 protein levels at 32 1C with disappearance of abundant levels of p53 detected at 37 1C. Hence, such comparative study confirms that, irrespective of cell context, p53 is a negative regulator of DJ-1.
To assess how p53 affects DJ-1 protein levels, we wondered whether p53 could be influencing DJ-1 protein degradation. To test this possibility, we incubated p53
þ / þ and p53 À/À MEFs with cycloheximide, an inhibitor of de novo protein synthesis. In the p53 wildtype scenario, it appears that DJ-1 is protected from degradation during the first 3 h of cycloheximide treatment as we observe a slight induction in DJ-1 protein levels (Figure 2a ). Stabilized protein expression followed by an arrest of protein synthesis has already been described as a consequence of inhibition of proteasomal degradation (Shenkman et al., 2007) . However, during longer incubation times with cycloheximide (5 h), degradation resumes and DJ-1 levels decrease to almost half of those observed in untreated cells. Surprisingly, we observed that DJ-1 degradation is significantly inhibited in p53
MEFs. There, its expression was only affected after very long incubations with cycloheximide (that is, 16 h). Hence, p53 suppression diminishes DJ-1 clearance and consequently, contributes to the accumulation of the DJ-1 protein.
As formation of a stable homodimer is essential for proper DJ-1 function , we investigated whether, in p53-deficient context, dimerization of DJ-1 protein can occur properly. We transfected p53 Cells were co-transfected with a constant amount of phRluc-N3/DJ-1 as BRET donor, and increasing quantities of pEYFP-N1/DJ-1 as BRET acceptor. To have a constant amount of transfected DNA in all wells, pEYFP-N1 was added in decreasing quantities. Cells were trypsinized 24 h after transfection, and seeded for BRET experiment. On the following day, the R-luc substrate coelentherazin-h was added 15 min before reading. Energy transfer was quantified using the BRET ratio, defined as the ratio between emission of fluorescence signal and luminescent signal: Luminescence (L) and fluorescence (F) signals (485 and 530 nm, respectively) were measured using a Tristar multitechnology reader (Berthold, Thoiry, France) and the F/L ratio was calculated for each point. The F 0 /L 0 value (transfection with no pEYFP-N1/DJ-1) was substracted from each ratio, and the origin of the obtained curve was 0.0 mBRET Unit. Bret values are expressed as percentage of BRET. Data are expressed as the mean ± s.d. of results from three independent experiments.
DJ-1/p53 connection during cell transformation S Vasseur et al signal, or DJ-1 homodimer formation, independent of p53 status (Figure 2b ). Overall, high levels of DJ-1 protein in p53-null cells correlates with enhanced DJ-1 stability and intact homo-dimerization of the DJ-1 protein.
Given the existing link between DJ-1 and the process of transformation (Nagakubo et al., 1997) , it is important to address whether DJ-1 enhancement following p53 deletion is dependent on the E1A-Ras-mediated cellular transformation process. To this end, we challenged early passaged p53 þ / þ and p53 À/À primary MEFs with doxorubicin and measured DJ-1 protein levels. Interestingly, we observed a reduction in DJ-1 protein after p53 induction by treatment, but p53 deficiency was not correlated with elevated DJ-1 levels (Figure 3a) , suggesting that DJ-1 induction by loss of p53 is exclusively observed in transformed MEFs. To note, DJ-1 downregulation after DNA damage is exclusively correlated to p53 induction, as it is not observed in p53 À/À primary or transformed MEFs. We next analyzed levels of DJ-1 protein in a variety of tissues from p53 þ / þ and p53 À/À mice, specifically lymphoid organs subjected to tumor formation after p53 inactivation. We could not detect any differences in DJ-1 levels in nontumoral organs from p53 þ / þ and p53 À/À mice. However, we observed increased DJ-1 levels in p53 À/À lymphoid organs harboring tumors as compared with corresponding control samples (Figure 3b) . Therefore, in the context of p53 deletion, cellular and genetic events leading to transformation definitively contribute to the elevation of DJ-1, and such elevation is greatly dependent on tumor initiation process in vivo.
It is well established that p53 can induce PTEN expression in certain cell types (Stambolic et al., 2001) , and then leads to the inactivation of AKT. In deleted or mutated p53 cell context, AKT activation is not inhibited (You et al., 2004; Dong et al., 2009) , which results in proliferation of the mutated cells. As DJ-1 is known to exert oncogenic effects via phosphorylation of AKT at Ser473 (pAKT) (Kim et al., 2005) , we hypothesized that, when p53 is deleted, subsequent upregulation of DJ-1 protein could serve as a strong inducer of pAKT. In thymoma from p53 À/À mice, which harbor strong DJ-1 levels, we have effectively detected high levels of pAKT (Figure 3c ). We next compared levels of pAKT in p53 þ / þ and p53 À/À MEFs with and without DJ-1 knockdown. Silenced RNA-mediated depletion of DJ-1 resulted in a strong inhibition of pAKT in p53 wild-type cells. Consistent with previous reports, we observed an increase in pAKT in p53-depleted and p53 À/À mice, or from p53 À/À mice developing tumors. Total protein lysates from thymus, liver, spleen and lymph nodes (LN) were prepared from 4-weeks-old p53 À/À mice not developing tumors (Healthy organs) or from 6-months-old p53 þ / þ healthy or p53 À/À -tumor bearing mice (Tumors (Mice#1 or #2) ). Lysates were analyzed by western blotting to detect DJ-1 protein. b-actin (detected by antib-actin, Sigma Aldrich) is used as a loading control. Levels of DJ-1 are normalized to b-actin and expressed as fold change relative to base expression in thymus from p53 þ / þ and p53 À/À mice. (c) Total protein lysates of thymus from healthy p53 þ / þ and p53 À/À mice (H), or from p53 À/À mice developing tumors (T1 and T2) described in (b), were analyzed by western blotting to detect total and phosphorylated AKT (pAKT). Levels of pAKT are normalized to total AKT and expressed as fold change relative to base expression in p53
À/À MEFs were transfected using RNAiMAX Lipofectamine (Invitrogen, CergyPontoise, France) with control or mouse DJ-1 siRNA (Si-C and Si-DJ-1, respectively, Santa Cruz Biotechnology). Levels of DJ-1, total and phosphorylated AKT (pAKT) (using anti-AKT and anti-pSer473AKT, Cell signalling, Ozyme, Saint Quentin Yvelines, France) were determined by western blotting in lysates 48 h after transfection. Levels of DJ-1 are normalized to b-tubulin and expressed as fold change relative to base expression determined using Si-C in p53
are normalized to total AKT in p53 þ / þ or p53 À/À , and expressed as fold change relative to base expression in Si-Cp53 þ / þ MEFs.
DJ-1/p53 connection during cell transformation S Vasseur et al cells, and interestingly, we demonstrate that DJ-1 is required for this full activation of AKT as its silencing leads to a significant reduction of pAKT in p53 À/À cells (Figure 3d ).
To take in consideration previous studies showing that DJ-1 represses p53 activity, we investigated DJ-1 influence on p53 activation during oxidative stress in our cell model. Zhan et al. (2010) recently showed that the ATM/AKT/p53 pathway is involved in oxidative stress response and that there is a concomitant increase in activation of AKT and phosphorylation of p53 at Ser15 (Ser15p53), following H 2 O 2 treatment. Hence, it appeared interesting to analyze Ser15p53 in MEFs treated with H 2 O 2 with and without DJ-1 knockdown. Interestingly, increased level of Ser15p53 following oxidative stress was partly impaired after depletion of DJ-1 (Figure 4a ). These data suggest that DJ-1 is critical for full activation of p53 and could participate in p53-mediated cell response to oxidative stress. Our present research highlights an interesting crosstalk between DJ-1 and p53, in which DJ-1 rapidly activates p53 following oxidative stress, and then p53, in a negative feedback loop, decreases DJ-1 and consequently AKT activation preventing excessive proliferation of transformed cells. However, it is still not clear whether the AKT/DJ-1/p53 pathway has a role in the antioxidant function of p53.
p53-deficient cells show intracellular accumulation of ROS, excessive oxidation of DNA, increased mutation rate, which can all be prevented by incubation of these cells with antioxidant N-acetylcysteine (Cano et al., 2009) . This characteristic can be related to another welldescribed function of DJ-1: its ability to scavenge oxidants during oxidative stress (Kahle et al., 2009) . To determine whether the increase of DJ-1 protein in p53 À/À cells is correlated with elevated ROS production in these cells, we first incubated p53 þ / þ or deficient MEFs with N-acetylcysteine. Antioxidant use abrogated DJ-1 induction in p53 À/À MEFs, suggesting that DJ-1 overexpression in p53-deficient cells is a result of increased intracellular ROS content (Figure 4b ). We next examined whether DJ-1 can influence p53-dependent cellular ROS content. Using the DCF probe, we þ / þ MEFs were transfected with control or mouse DJ-1 siRNA (Si-C and Si-DJ-1, respectively). Whole-cell lysates were prepared from p53 þ / þ MEFs 24 h after plating followed by H 2 O 2 treatment (50 mM, 4 h) and assessed by western blot for DJ-1, total and phosphorylated p53 (ser15p53). Levels of ser15p53 are normalized to total p53 and expressed as as fold change relative to base expression observed in Si-Cp53 þ / þ -untreated MEFs. Levels of ser15p53 were determined using anti-pSer15p53 (Cell signalling). (b) Whole-cell lysates were prepared 24 h after plating followed by N-acetylcysteine treatment (5 mM). Levels of DJ-1, p53 and b-tubulin were determined by western blotting. Levels of DJ-1 and p53 are normalized to b-tubulin and expressed as fold change relative to base expression observed in p53 þ / þ samples. (c) Cells were assessed for ROS content at least 24 h after plating. Before harvesting they were further cultured for 15 min with 5 mmol/l dichlorofluorescein (DCF) diacetate (Sigma-Aldrich), which is oxidized in the presence of ROS into green fluorescent DCF, fluorescence of which was assessed by flow cytometry on a FACSCalibur cytometer (BD Biosciences, Le Pont de Claix, France). Histograms show DCF mean of ROS containing Si-C and Si-DJ-1p53 þ / þ and Si-C and Si-DJ-1p53 À/À MEFs. Columns represent mean of three independent experiments (expressed as fold induction compared to Si-Cp53 þ / þ MEFs). (Sablina et al., 2005) . Surprisingly, in p53 À/À cells, suppression of DJ-1 expression is sufficient to significantly decrease the DCF mean (Figure 4c) . Thus, DJ-1 protein level is tightly correlated with increased intracellular ROS generation and might be responsible for such oxidative status of p53-mutated cells. Whether DJ-1 allows increased ROS production or is responsible for a defective pathway of ROS degradation remains to be elucidated. Cells submitted to oxidative stress are prone to oxidative DNA damage, which is known to be associated with an increased incidence of mutations. In p53-deficient cancer cells, downregulation of p53-dependent antioxidant genes strongly contributes to their mutant phenotype. Therefore, as DJ-1 appears to be responsible for ROS accumulation in p53-deficient cells, it represents an important component of oncogenic pathways induced after inactivation of p53 and could largely contribute to genetic alterations and promotion of tumor cell survival. Here, the new role of DJ-1 as an enhancer of cellular ROS content following p53 deletion, contrasts with its well-described anti-oxidative properties in neurodegenerative disease. However, such data could reveal a new facet of its neoplastic potential, especially in a p53-depleted transformed context.
Although high level of DJ-1 expression was shown to correlate with p53 mutation in glioblastomas, functional significance of this relationship has still not been elucidated (Hinkle et al., 2011) . In our study, we propose that high DJ-1 level in p53-deficient cells has significant repercussions for neoplasic transformation. Further definition of the pathways activated by DJ-1 in p53-deficient cells will help us to better understand its oncogenic role. Moreover, as DJ-1 is expressed in a multitude of cancers, it appears also important, for clinical relevance, to correlate its expression with p53 status in tumors as this status appears determinant for DJ-1's function as an enhancer of ROS accumulation.
In summary, p53 repression of DJ-1 could constitute another mechanism by which p53, a barrier for tumor development, supresses oncogene-mediated transformation. In addition, repercussions of high DJ-1 expression on AKT activation and ROS production in p53-depleted cells shed light on novel oncogenic potential of DJ-1 during transformation process and tumorigenesis. Given the plethora of DJ-1 and p53 capabilities, it would be valuable to understand the functional crosstalk between these two proteins in such pathologies as cancer and neurodegenerative diseases.
